Company Search:
Advanced Search
Sponsored Links
Egypt International Pharmaceuticals Company Snapshot
Egypt International Pharmaceuticals operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Egypt International Pharmaceuticals with three other pharmaceutical manufacturers in Middle East: October Pharma SAE (2018 sales of 400.69 million Egyptian Pounds [US$24.67 million] ), Dar Al Dawa Development and Investment Company PSC of Jordan (55.10 million Jordanian Dinars [US$77.71 million] of which 75% was Pharmaceuticals), and Alexandria Pharmaceuticals and Chemical Industries Co (650.00 million Egyptian Pounds [US$40.03 million] ).

Sales Analysis. During the year ended December of 2018, sales at Egypt International Pharmaceuticals were 2.82 billion Egyptian Pounds (US$173.38 million). This is an increase of 11.4% versus 2017, when the company's sales were 2.53 billion Egyptian Pounds. This was the fifth consecutive year of sales increases at Egypt International Pharmaceuticals (and since 2013, sales have increased a total of 107%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Egypt International Pharmaceuticals
  Stock Performance Chart for Egypt International Pharmaceuticals
  Stock Data: Recent Stock Performance:
  Current Price (10/10/2019): 69.99
(Figures in Egyptian Pounds)
1 Week 0.0%   13 Weeks 4.2%  
4 Weeks -11.3%   52 Weeks -20.5%  
Egypt International Pharmaceuticals Key Data:
  Ticker: PHAR Country: Egypt
  Exchanges: CAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 2,815,569,997
(Year Ending Jan 2019).
Employees: 2,039
  Currency: Egyptian Pounds Market Cap: 6,940,943,295
  Fiscal Yr Ends: December Shares Outstanding: 99,170,500
  Share Type: Ordinary Closely Held Shares: 50,464,312
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.